ImmunXperts

Foundation date

15/05/2014

Sector

#Biotechnology / R&D Services

Subsector

Therapeutic areas

ImmunXperts offers a wide range of in silico and in vitro assays to companies developing new drugs. The purpose of these tests is to help our partners select the best and less risky drug candidates before further development into the clinical phases. We want to be a trusted partner for our clients by thinking and working together; acting as their mobile development team in the areas where they need us.

Upcoming events

Latest news

  • UCB announces positive Phase 3 studies for bimekizumab in hidradenitis suppurativa

    1 day ago

  • Company growth prompts Connected-Pathology relocation to larger laboratory facilities to accommodate increase in study capacity

    Tuesday December 6th 2022

  • Japan welcomes companies, startups and knowledge institutions from Flanders

    Friday December 2nd 2022